Financials AS Latvijas Juras medicinas centrs
Equities
UOM
LV0000100741
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9 EUR | 0.00% | 0.00% | -15.09% |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|
Capitalization 1 | 3.152 | 3.984 | 3.968 | 5.96 | 10.16 |
Enterprise Value (EV) 1 | 1.761 | 2.14 | 1.981 | 4.195 | 9.143 |
P/E ratio | 6.22 x | -49.9 x | 23.7 x | 21.8 x | 11.5 x |
Yield | 10.2% | 2.01% | - | 0.94% | 1.57% |
Capitalization / Revenue | 0.54 x | 0.6 x | 0.55 x | 0.84 x | 1.09 x |
EV / Revenue | 0.3 x | 0.32 x | 0.27 x | 0.59 x | 0.98 x |
EV / EBITDA | 4.27 x | 17.6 x | 5.71 x | 8.23 x | 7.83 x |
EV / FCF | -2.51 x | 12.3 x | 9.7 x | 24.5 x | -9.32 x |
FCF Yield | -39.8% | 8.14% | 10.3% | 4.08% | -10.7% |
Price to Book | 0.54 x | 0.74 x | 0.72 x | 1.08 x | 1.6 x |
Nbr of stocks (in thousands) | 800 | 800 | 800 | 800 | 800 |
Reference price 2 | 3.940 | 4.980 | 4.960 | 7.450 | 12.70 |
Announcement Date | 4/27/18 | 4/29/19 | 2/21/20 | 4/21/21 | 4/28/22 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|
Net sales 1 | 5.877 | 6.674 | 7.27 | 7.081 | 9.364 |
EBITDA 1 | 0.4125 | 0.1216 | 0.3468 | 0.5094 | 1.168 |
EBIT 1 | 0.1411 | -0.0791 | 0.1499 | 0.2746 | 0.8809 |
Operating Margin | 2.4% | -1.18% | 2.06% | 3.88% | 9.41% |
Earnings before Tax (EBT) 1 | 0.4938 | -0.0793 | 0.1678 | 0.2746 | 0.8809 |
Net income 1 | 0.5065 | -0.0798 | 0.1678 | 0.2736 | 0.8803 |
Net margin | 8.62% | -1.2% | 2.31% | 3.86% | 9.4% |
EPS 2 | 0.6331 | -0.0998 | 0.2097 | 0.3419 | 1.100 |
Free Cash Flow 1 | -0.7013 | 0.1743 | 0.2042 | 0.1712 | -0.9805 |
FCF margin | -11.93% | 2.61% | 2.81% | 2.42% | -10.47% |
FCF Conversion (EBITDA) | - | 143.27% | 58.86% | 33.6% | - |
FCF Conversion (Net income) | - | - | 121.69% | 62.58% | - |
Dividend per Share 2 | 0.4000 | 0.1000 | - | 0.0700 | 0.2000 |
Announcement Date | 4/27/18 | 4/29/19 | 2/21/20 | 4/21/21 | 4/28/22 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - |
Net Cash position 1 | 1.39 | 1.84 | 1.99 | 1.77 | 1.02 |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow 1 | -0.7 | 0.17 | 0.2 | 0.17 | -0.98 |
ROE (net income / shareholders' equity) | 8.04% | -1.42% | 3.07% | 4.97% | 14.8% |
ROA (Net income/ Total Assets) | 1.15% | -0.71% | 1.33% | 2.38% | 7.06% |
Assets 1 | 44.02 | 11.25 | 12.66 | 11.5 | 12.47 |
Book Value Per Share 2 | 7.270 | 6.770 | 6.880 | 6.900 | 7.930 |
Cash Flow per Share 2 | 1.740 | 2.310 | 2.480 | 2.210 | 1.270 |
Capex 1 | 0.61 | 0.09 | 0.19 | 0.52 | 1.11 |
Capex / Sales | 10.3% | 1.3% | 2.62% | 7.27% | 11.85% |
Announcement Date | 4/27/18 | 4/29/19 | 2/21/20 | 4/21/21 | 4/28/22 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-15.09% | 7.82M | |
-17.57% | 16.76B | |
+3.60% | 12.65B | |
+4.64% | 11.86B | |
+4.28% | 10.28B | |
+29.06% | 8.67B | |
-6.94% | 7.6B | |
+6.55% | 6.8B | |
+8.59% | 6.52B | |
+46.39% | 4.53B |
- Stock Market
- Equities
- UOM Stock
- Financials AS Latvijas Juras medicinas centrs